Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
Mark T Bergmann,1 Jon I Williams,2 Paul J Gomes3On behalf of the Bepotastine Besilate Ophthalmic Solutions Clinical Study Group 1Eye Care Associates of Greater Cincinnati, Inc., Cincinnati, OH, USA; 2Bausch + Lomb, Irvine, CA, USA; 3Ora, Inc., Andover, MA, USA Purpose: To examine the pooled per-p...
Main Authors: | Bergmann MT, Williams JI, Gomes PJ |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-08-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/treatment-of-allergic-conjunctivitis-with-bepotastine-besilate-ophthal-peer-reviewed-article-OPTH |
Similar Items
-
Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis
by: Cavet ME, et al.
Published: (2018-03-01) -
Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
by: McCabe CF, et al.
Published: (2012-10-01) -
Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
by: Shruti Ayyappanavar, et al.
Published: (2021-01-01) -
Bepotastine besilate: A novel anti-histamine
by: Kiran Godse, et al.
Published: (2017-01-01) -
Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis
by: Jeremy B Wingard, et al.
Published: (2011-02-01)